Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 September 2019 | Story Valentino Ndaba | Photo Charl Devenish
Arbor tree plant
To celebrate National Arbor Week the University of the Free State has embarked on a drive to plant 150 trees during the month of September

If you’ve wondered whether Arbor Month was important, you only have to look at the destruction and long-term damage that deforestation causes to the environment and the world’s inhabitants. To observe National Arbor Month, the University of the Free State’s has (UFS) kick-started a drive to plant 150 trees during the month of September.

To launch this initiative, the Rector and Vice-Chancellor, Prof Francis Petersen, alongside members of the rectorate, assisted the University Estates team in planting the first 10 of 100 trees at the Bloemfontein Campus on Wednesday 4 September 2019. A total of 50 trees will be planted on the Qwaqwa Campus.

Towards a sustainable future

“We have gone through periods of drought in the Free State that have severely impacted not only the plants but the trees on our campuses. The idea is to emphasise sustainability, and as a university, we believe that sustainability is important. As an education institution, we have to look at the generations that are still to come to our campuses,” said Prof Petersen.

He urged the Kovsie community to ensure that all practices across the campuses are linked to global standards of sustainability. “As we develop over the next couple of months and years, we will get much closer alignment between what we are doing as a university and the Sustainable Development Goals.

Drought-resistant man-made forests

Clusters of mini forests across the campuses will be created with a variety of trees including the karee, white karee, white stinkwood, and wild olive. These indigenous trees can adapt well to different soils including those that are poorly drained.

Celebrating Arbor Week

This year’s campaign was held under the theme Forests and Sustainable Cities. As part of the celebration, University Estates made a commitment to the environment by embarking on the green initiative which includes other project such as the upgrade of Red Square on the Bloemfontein Campus.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept